• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乌干达患者结直肠癌中p53表达与组织病理学特征的关系

p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.

作者信息

Rambau Peter F, Odida Michael, Wabinga Henry

机构信息

Department of Pathology, Bugando University College of Health Sciences, Mwanza Tanzania.

出版信息

Afr Health Sci. 2008 Dec;8(4):234-8.

PMID:20589130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2887007/
Abstract

BACKGROUND

It has been shown that colorectal carcinoma is increasing in incidence in African countries. This could be due to change in life style. Molecular pathogenesis of colorectal cancer commonly involves mutation in p53 gene which leads to expression of p53 protein in tumor cells. Expression of p53 protein has been associated with poor clinical outcome and reduced survival in patients.

OBJECTIVE

This was a retrospective laboratory based study carried out in the Department of Pathology Makerere University, Kampala, Uganda. The aim of the study was to evaluate the expression of p53 protein in colorectal carcinoma in Ugandan patients, specifically its association with histological types, degree of differentiation, sites of the tumor and demographic characteristics of the patients.

METHODS

Immunohistochemistry was carried out on 109 patient's paraffin embedded tissue blocks of colorectal carcinoma diagnosed in the Pathology Department, Faculty of Medicine Makerere University Kampala during the period 1995 to 2005. The indirect immunoperoxidase method using monoclonal antibody p53 DO-7 and Envision (+) Dual link system-HRP to detect p53 expression was used. Haematoxylin and eosin stain was used for evaluation of histological types and degree of differentiation of the tumors. Topography of the tumors and demographic data were obtained from accompanying histological request forms.

RESULTS

Out of 109 patient's tissue blocks that were studied, 61 cases (56%) expressed p53 protein in the nucleus of malignant cells. Right sided colonic tumors were commoner (53.2%) than left sided colonic tumors (46.8%). p53 protein was expressed more in left sided colonic tumors with a significant difference (p<0.05), it was also expressed more in well differentiated tumors and non mucinous adenocarcinomas but with no significant difference (p>0.05). p53 expression was not affected by age or sex.

CONCLUSION

Frequency of p53 protein expression in Ugandan patients did not differ from that reported in the other parts of the world. It was expressed more in the left sided colonic tumors and this could support the hypothesis that right and left colonic tumors could have different pathogenesis and probably also responsible for difference in prognosis in these two topographic sites.

摘要

背景

研究表明,非洲国家结直肠癌的发病率正在上升。这可能是由于生活方式的改变。结直肠癌的分子发病机制通常涉及p53基因的突变,这会导致肿瘤细胞中p53蛋白的表达。p53蛋白的表达与患者不良的临床结局和生存率降低有关。

目的

这是一项基于实验室的回顾性研究,在乌干达坎帕拉马凯雷雷大学病理系开展。该研究的目的是评估乌干达患者结直肠癌中p53蛋白的表达,特别是其与组织学类型、分化程度、肿瘤部位以及患者人口统计学特征的关联。

方法

对1995年至2005年期间在坎帕拉马凯雷雷大学医学院病理科诊断的109例结直肠癌患者的石蜡包埋组织块进行免疫组织化学检测。采用间接免疫过氧化物酶法,使用单克隆抗体p53 DO-7和Envision(+)双链系统-HRP检测p53表达。苏木精和伊红染色用于评估肿瘤的组织学类型和分化程度。肿瘤的部位和人口统计学数据来自随附的组织学申请表。

结果

在研究的109例患者组织块中,61例(56%)在恶性细胞核中表达p53蛋白。右侧结肠肿瘤(53.2%)比左侧结肠肿瘤(46.8%)更常见。p53蛋白在左侧结肠肿瘤中的表达更多,差异有统计学意义(p<0.05),在高分化肿瘤和非黏液腺癌中的表达也更多,但差异无统计学意义(p>0.05)。p53表达不受年龄或性别的影响。

结论

乌干达患者中p53蛋白表达的频率与世界其他地区报道的频率没有差异。它在左侧结肠肿瘤中的表达更多,这可能支持这样的假设,即左右侧结肠肿瘤可能有不同的发病机制,也可能是这两个部位预后差异的原因。

相似文献

1
p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.乌干达患者结直肠癌中p53表达与组织病理学特征的关系
Afr Health Sci. 2008 Dec;8(4):234-8.
2
Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression.结直肠黏液腺癌:p16和p53表达的临床病理特征及意义
Dis Colon Rectum. 2006 Sep;49(9):1275-83. doi: 10.1007/s10350-006-0650-y.
3
Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.具有印戒细胞成分的结直肠癌和具有黏液成分的结直肠癌的独特分子特征。
Mod Pathol. 2006 Jan;19(1):59-68. doi: 10.1038/modpathol.3800482.
4
Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.结直肠印戒细胞癌和黏液性 patterned 癌的基因组改变。
Pathol Res Pract. 2019 Oct;215(10):152566. doi: 10.1016/j.prp.2019.152566. Epub 2019 Jul 27.
5
[Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].[黏液性和印戒细胞分化对结直肠癌患者流行病学、组织学、分子生物学特征及预后的影响]
Zentralbl Chir. 2013 Aug;138(4):427-33. doi: 10.1055/s-0031-1283870. Epub 2012 Jan 24.
6
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.散发性早发性结直肠腺癌的临床病理和分子特征:一种具有高频印戒细胞分化、直肠和乙状结肠受累以及不良形态学特征的腺癌。
Mod Pathol. 2012 Aug;25(8):1128-39. doi: 10.1038/modpathol.2012.61. Epub 2012 Apr 6.
7
Clinicopathological characteristics, microsatellite instability, and expression of mucin core proteins and p53 in colorectal mucinous adenocarcinomas in relation to location.结直肠黏液腺癌的临床病理特征、微卫星不稳定性以及黏蛋白核心蛋白和p53的表达与肿瘤位置的关系
Virchows Arch. 2006 Jul;449(1):40-7. doi: 10.1007/s00428-006-0212-7. Epub 2006 Apr 28.
8
Microsatellite instability in young patients with colorectal cancer.
Pathol Int. 1998 Aug;48(8):586-94. doi: 10.1111/j.1440-1827.1998.tb03955.x.
9
Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries.中东国家结直肠癌中不同的DNA甲基化模式和基因突变频率。
Clin Cancer Res. 2005 Dec 1;11(23):8281-7. doi: 10.1158/1078-0432.CCR-05-1000.
10
Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.结直肠癌中增殖标志物、p53表达与组织学结果的相关性
J Gastrointestin Liver Dis. 2007 Jun;16(2):133-9.

引用本文的文献

1
Comparison of PD-L1, CTR-1, VEGF, and p53 expression in sensitive and resistant epithelial ovarian cancer (EOC) patients to platinum-based chemotherapy.铂类化疗敏感和耐药的上皮性卵巢癌(EOC)患者中PD-L1、CTR-1、VEGF和p53表达的比较。
Narra J. 2025 Apr;5(1):e1419. doi: 10.52225/narra.v5i1.1419. Epub 2025 Jan 6.
2
Interplay of LncRNA TUG1 and TGF-β/P53 Expression in Colorectal Cancer.长链非编码 RNA TUG1 与 TGF-β/P53 表达在结直肠癌中的相互作用。
Asian Pac J Cancer Prev. 2023 Nov 1;24(11):3957-3968. doi: 10.31557/APJCP.2023.24.11.3957.
3
Colorectal adenocarcinoma in Uganda: are right-sided and left-sided colon cancers two distinct disease entities?乌干达结直肠腺癌:右侧结肠癌和左侧结肠癌是两种不同的疾病实体吗?
World J Surg Oncol. 2023 Jul 22;21(1):215. doi: 10.1186/s12957-023-03094-7.
4
Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.运用机器学习方法发现左右侧结肠癌的分子差异。
BMC Cancer. 2020 Oct 19;20(1):1012. doi: 10.1186/s12885-020-07507-8.
5
Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma.左、右结肠癌中差异表达基因的筛选与鉴定。
Biomed Res Int. 2020 Jan 21;2020:8465068. doi: 10.1155/2020/8465068. eCollection 2020.
6
The roles of p53 and XPO1 on colorectal cancer progression in Yemeni patients.p53和XPO1在也门患者结直肠癌进展中的作用。
J Gastrointest Oncol. 2019 Jun;10(3):437-444. doi: 10.21037/jgo.2019.01.17.
7
Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.右半结肠癌、左半结肠癌和直肠癌的蛋白表达谱、KRAS 和 BRAF 突变及预后的差异。
Sci Rep. 2017 Aug 11;7(1):7882. doi: 10.1038/s41598-017-08413-z.
8
Colorectal cancer in patients seen at the teaching hospitals of Guadeloupe and Martinique: discrepancies, similarities in clinicopathological features, and p53 status.瓜德罗普岛和马提尼克岛教学医院收治的结直肠癌患者:临床病理特征及p53状态的差异与相似之处
BMC Clin Pathol. 2014 Mar 29;14(1):12. doi: 10.1186/1472-6890-14-12.

本文引用的文献

1
Different p53 mutation patterns in colorectal tumors from smokers and nonsmokers.吸烟者与非吸烟者结直肠肿瘤中不同的p53突变模式。
Environ Mol Mutagen. 2006 Aug;47(7):527-32. doi: 10.1002/em.20222.
2
Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.p16、p53和p63在结直肠腺瘤和腺癌中的免疫组化表达
Dis Colon Rectum. 2006 May;49(5):588-94. doi: 10.1007/s10350-006-0515-4.
3
Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma.bcl-2和p53表达在结直肠癌中的预后意义
J Zhejiang Univ Sci B. 2005 Dec;6(12):1163-9. doi: 10.1631/jzus.2005.B1163.
4
P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.结直肠癌肝转移灶的P53突变分析:与实际生存、血管生成状态及P53过表达的关系
Clin Cancer Res. 2005 Jun 1;11(11):4067-73. doi: 10.1158/1078-0432.CCR-04-2389.
5
Expression of cellular FLICE-inhibitory protein and its association with p53 mutation in colon cancer.细胞FLICE抑制蛋白在结肠癌中的表达及其与p53突变的关系。
World J Gastroenterol. 2005 Apr 28;11(16):2482-5. doi: 10.3748/wjg.v11.i16.2482.
6
Cancer survival in Kampala, Uganda.乌干达坎帕拉的癌症生存率。
Br J Cancer. 2005 May 9;92(9):1808-12. doi: 10.1038/sj.bjc.6602540.
7
The clinical significance of p53, p21, and p27 expressions in rectal carcinoma.p53、p21和p27表达在直肠癌中的临床意义。
Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):38-44. doi: 10.1097/00129039-200503000-00007.
8
Prognostic implications of hMLH1 and p53 immunohistochemical status in right-sided colon cancer.
Dis Colon Rectum. 2004 Dec;47(12):2086-91; discussion 2091-2. doi: 10.1007/s10350-004-0710-0.
9
Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.胸苷酸合成酶表达、p53、bcl-2、Ki-67和p27在结直肠癌中的表达:与肿瘤复发和生存的关系
Tumour Biol. 2004 Sep-Dec;25(5-6):258-63. doi: 10.1159/000081389.
10
p53 protein accumulation in colorectal cancer tissue has prognostic value only in left-sided colon tumours.
Cancer Detect Prev. 2004;28(4):252-9. doi: 10.1016/j.cdp.2004.05.001.